Archives for September 19, 2022

← 2022
Exagen on why AVISE test can end the ‘diagnostic odyssey’

Exagen on why AVISE test can end the ‘diagnostic odyssey’

Autoimmune diagnostics life sciences company Exagen is heralding the completion of the CAPSTONE study as evidence that its AVISE Lupus test is more clinically effective than traditional ANA methods (tANA), benefiting patients, providers and payers by...